Zonagen (zona) - good buy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BDR who wrote (6642)	5/11/1999 5:12:00 AM
From: Linda Kaplan	of 7041

Interesting. You also left out this comment from your labpuppy source: It appears that Schering-Plough's (SGP) Vasomax (for male erectile dysfunction – Eck!) has shown only a response rate of 34-48% (versus 63-82% for Pfizer's Viagra). They are still testing to see if Vasomax has a nitrate interaction problem (i.e. like Viagra). Vasomax has an additional problem in that it causes fainting when patients stand. Most investors believe that this product will not sell well. Most analysts think that this product's peak sales will be around only $100-$200 million (at best). Linda

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next